{
 "generic_name": "Mesalamine Capsule, Extended Release",
 "slug": "mesalamine-capsule-extended-release",
 "brand_names": [
  "Mesalamine",
  "Pentasa"
 ],
 "fda_status": [
  "To Be Discontinued"
 ],
 "last_fda_update": "09/16/2026",
 "first_posted": "08/25/2026",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "package_ndc": "0378-1375-78",
   "presentation": "Mesalamine, Capsule, Extended Release, .375 g (NDC 0378-1375-78)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Discontinuation of the manufacture of the drug"
  },
  {
   "company": "Takeda Pharmaceuticals USA Inc.",
   "package_ndc": "54092-189-81",
   "presentation": "Pentasa, Capsule, Extended Release, 250 mg (NDC 54092-189-81)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Product is anticipated to be available until December 31, 2027"
  },
  {
   "company": "Takeda Pharmaceuticals USA Inc.",
   "package_ndc": "54092-191-12",
   "presentation": "Pentasa, Capsule, Extended Release, 500 mg (NDC 54092-191-12)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Product is anticipated to be available until December 31, 2027"
  }
 ],
 "changes": []
}